Insider holders · CIK 0001668243
UroGen Pharma Ltd. · URGN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| ProQuest Associates IV LLC10% Owner | 1,242,031 | — | 1,242,031 | Nov 29, 2017 · 5:07 pm EST | Form 4 |
| ProQuest Investments IV, L.P.10% Owner | 1,242,031 | — | 1,242,031 | Nov 29, 2017 · 5:07 pm EST | Form 4 |
| Alain Schreiber10% Owner | 1,242,031 | — | 1,242,031 | Nov 29, 2017 · 5:07 pm EST | Form 4 |
| Jay Moorin10% Owner | 1,242,031 | — | 1,242,031 | Nov 29, 2017 · 5:07 pm EST | Form 4 |
| Ran NussbaumDirector | — | 452,162 | 452,162 | Jan 10, 2019 · 5:16 pm EST | Form 3 |
| Arie BelldegrunDirector | 84,211 | — | 84,211 | Jan 10, 2019 · 5:08 pm EST | Form 3 |
| Mark SchoenbergChief Medical Officer | 59,882 | — | 59,882 | Sep 9, 2026 · 2:37 pm EDT | Form 4 |
| Jason Drew SmithGeneral Counsel | 53,141 | — | 53,141 | Sep 9, 2026 · 2:35 pm EDT | Form 4 |
| Ron BentsurChief Executive Officer | 38,113 | — | 38,113 | Jan 10, 2019 · 5:09 pm EST | Form 3 |
| James A. Robinson Jr.Director | 8,000 | — | 8,000 | Aug 28, 2026 · 4:01 pm EDT | Form 4 |
| Stephen MullennixChief Operating Officer | 4,230 | — | 4,230 | Mar 7, 2019 · 9:44 pm EST | Form 4 |
| Peter P. PfreundschuhCFO | 1,000 | — | 1,000 | Jan 10, 2019 · 5:17 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.